Biotech News
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
ir.supernus.com2026-05-06 21:06 EST
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A.